Evaluation of second-line and subsequent targeted therapies in metastatic renal cell cancer (mRCC) patients treated with first-line cediranib
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Gregory R. Pond |
| Publication date | November 1, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |